NCT02009813View on ClinicalTrials.gov

Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session.

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
ObesityType 2 Diabetes
Interventions
PROCEDURE

Hyperbaric Oxygen Therapy

Participants will undergo 2 treatments of hyperbaric oxygen. Each treatment consists of 90 minutes compression at 2 atmospheres of pressure, with 30 minutes decompression back to 1 atmosphere. During this time, patients will be treated with 100% oxygen delivered via a hood system.

Trial Locations (1)

5000

Royal Adelaide Hospital, Adelaide

All Listed Sponsors
lead

University of Adelaide

OTHER

NCT02009813 - Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session. | Biotech Hunter | Biotech Hunter